ArticleJournal of biomedical science2013

Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance.

Kwang-Yu Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.